glp 1 and addiction treatment GLP-1 receptor agonists show promise in treating substance use disorders Veterans to test GLP-1 drugs

It may be due to the reduction of hepatocytes in cirrhosis patient, which promotes the secretion of HGF and then activates c-Met to increase hepatocytes proliferation

Accessing BPC-157 in Canada Canadian researchers and individuals interested in BPC-157 navigate a regulatory landscape that differs from both complete prohibition and full pharmaceutical approval

On the left is a diagram from a BPC-157 study and on the right from our in-vitro platelet-based tendon healing study (5)

The injection delivers these nutrients directly into the bloodstream, bypassing digestive absorption issues common in patients with gut disorders or post-bariatric surgery